# KBI Biopharma, Inc. – FDA Inspection, Sep 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/kbi-biopharma-inc/f7c07700-77b2-48bc-81f0-c04548a90ffe
Source feed: FDA_Inspections

> FDA inspection 1066025 of KBI Biopharma, Inc., September 12, 2018. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066025
- Company Name: KBI Biopharma, Inc.
- Inspection Date: 2018-09-12
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 0

## Related Documents

- FDA Inspection 1158021 - 2021-12-03
- [FDA Inspection 994318 - 2016-12-09](https://www.keypedia.com/records/fda_inspections/kbi-biopharma-inc/ea62a328-0c07-423d-8103-b58f260812c3)

## Related Officers

- Issuing Officer
- [Ralph M. Bernstein](https://www.keypedia.com/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- Issuing Officer

Company: https://www.keypedia.com/companies/kbi-biopharma-inc/0116f415-95dd-4a3f-a854-182d0314d5a5

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face